2024-11-20 18:30:13
Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes
Corporate/ 2023-07-24
Antengene Announces IND Approval in Chin...

This study is the third ATG-016 study to be conducted in China. Study highlights Antengene\'s robust SINE programs.

Vela Diagnostics Launches Focused (60 Genes) and Comprehensive (525 Genes) NGS-Based Pan-Cancer Panels
Health/ 2023-07-22
Vela Diagnostics Launches Focused (60 Ge...

HAMBURG,Germany,March 28,2022-- Vela Diagnostics announced today the launch of its new OncoKey® SL 60 and 525 Plus Panels. These next-ge...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release